CAPNS1 and intrahepatic cholangiocarcinoma: Patients suffering from ICC recurrence (15 of 33 patients) had higher Capn4 mRNA expression than those without recurrence (18 of 33 patients, 1.71±0.19 vs. 0.32±0.07, p<0.001, Fig. 2A).